Ulupreneurs in the news

A TechCrunch article highlighted Zum CEO Ritu Naryan as one of the featured speakers at TC Disrupt 2023.

Endpoints News headlined Astrazeneca’s partnership with Vaxess to develop skin patch mRNA vaccines for flu pandemic.

New York Post and several outlets featured FDA approval of Sequel’s newly designed tampon.

The Wall Street Journal and several other outlets featured FDA approval of Sequel’s newly designed tampon.

Fortune profiled Sequel’s CEO Amanda Calabrese and the firm’s efforts to take tampons to the next level.

TechCrunch profiled LeadSales’ targeting of LatAm conversation commerce in WhatsApp and their $3.7M raise.

CBS News Minnesota featured Irrigreen in a piece about how homeowners can conserve water while irrigating their lawns.

A Fortune article highlighted Hey Jane’s plans to expand beyond abortion services to provide other digital health treatments.

The Wall Street Journal featured Genesis Therapeutics’ $200M Series B round, which will help the firm find drugs discovered with artificial intelligence and assist them in entering clinical trials.

Geek Wire (and other outlets) headlined Bridge’s acquisition by Boundless, combining two immigration-focused startups.

CityBiz (and other outlets) headlined Swing Education’s $38M Series C raise to grow the pool of qualified substitute teachers and school district partners across the seven states and District of Columbia where Swing currently operates, and expand to new regions.

The Today Show featured the Parfait team in an in-depth piece about their passion in revolutionizing the custom wig industry through AI.

Forbes profiled Buzz Solutions and the firm’s work using AI to help protect the nation’s energy infrastructure and make it more efficient.